Table: begin end state 1 19 non-cytoplasmic 20 20 cytoplasmic 21 43 transmembrane 44 48 cytoplasmic 49 69 transmembrane 70 81 non-cytoplasmic 82 100 transmembrane 101 121 non-cytoplasmic 122 149 transmembrane 150 157 cytoplasmic 158 179 transmembrane 180 198 non-cytoplasmic 199 219 transmembrane 220 248 cytoplasmic 249 271 transmembrane 272 282 non-cytoplasmic 283 307 transmembrane 308 322 cytoplasmic 323 341 transmembrane 342 354 non-cytoplasmic 355 375 transmembrane 376 381 cytoplasmic 382 402 transmembrane 403 407 non-cytoplasmic 408 430 transmembrane 431 441 cytoplasmic 442 463 transmembrane 464 467 non-cytoplasmic
Input: >GFF4613 FitnessBrowser__WCS417:GFF4613 MIYEFHNQFDVTLSEEYRMAASPGFGLLAYAAIAIIALIVLIARYRLNPFIVITLVSIGL ALMAGMPADTIMGSYEAGVGKTLGHIALVVALGTMLGKMMAESGGAEQVARTLINRFGER NAHWAMVCIAFLVGLPLFFEVGFVLLVPIAFTVARRVGVSILMVGLPMVAGLSVVHALVP PHPAAMMAVLAYNASVGQTVLYAILIGIPTAIIAGPVYAKFIVPRIHLPAENPLERQFID REPRTRLPSFTLTMGTILLPVVLMMIGGWANVISSPGSAFNQFLLFIGNSVIALLVATLV SFWTLGIAQGFNRESILKFTNECLAPTASITLLVGAGGGLNRILVDAGVTNEILGLAHAF QLSPLVMGWLFAALMRIATGSATVAMTTASGVVAPVAMGLGYPHPELLVLATGAGSVIFS HVNDGGFWLIKEYFNMTVIQTFKTWTVLETLISVVAFGLTYGLSCIL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server